ArticleFrontiers in oncology2026

A serum metabolite-based machine learning model predicts response to neoadjuvant immunotherapy in mismatch repair-deficient colorectal cancer.

Tao Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.